Addressing second medical use infringement

• Analysis of recent ket cases and overview of varying jurisdictions
• Why we need global harmonization of patentability
• What must generic manufacturers do prior to product launch, where a second medical use patent is in force?
• What practical steps must a second medical use patent owner take when infringement is suspected?

Moderator: 
White & Case

Panellists: 
Lydia McNally, VP, Patent Head,  Oncology and US Patent Site Head, Novartis
Catherine Eckenswiller, Legal Counsel, IP and Contracts, VBI Vaccines
John Prince, Senior Patent Attorney, NIBR Novartis